Ocular Therapeutix
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $15,347 | $16,440 | $14,715 | $14,802 |
Gross Profit | 13,786 | 14,931 | 13,389 | 13,416 |
EBITDA | -45,998 | -39,625 | -59,877 | -24,109 |
EBIT | -40,581 | -60,797 | -25,067 | |
Net Income | -36,493 | -43,777 | -64,848 | -29,220 |
Net Change In Cash | 15,347 | 16,440 | 14,715 | 14,802 |
Free Cash Flow | -36,648 | -25,544 | -34,142 | -17,729 |
Cash | 427,220 | 459,690 | 483,038 | 195,957 |
Basic Shares | 166,992 | 165,824 | 132,021 | 84,429 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $58,443 | $51,494 | $43,522 | $17,403 |
Gross Profit | 53,162 | 46,954 | 39,116 | 15,320 |
EBITDA | -66,415 | -61,907 | -75,616 | -146,095 |
EBIT | -69,398 | -64,016 | -78,037 | -148,868 |
Net Income | -80,736 | -63,422 | -10,804 | -159,631 |
Net Change In Cash | 58,443 | 51,494 | 43,522 | 17,403 |
Cost of Revenue | -61,864 | -63,893 | 173,619 | |
Free Cash Flow | -76,321 | -63,318 | -66,744 | -54,395 |
Cash | 195,807 | 102,300 | 164,164 | 228,057 |
Basic Shares | 85,596 | 76,875 | 82,162 | 60,752 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.22 |
2024-06-30 | -$0.26 |
2024-03-31 | -$0.70 |
2023-12-31 | -$0.35 |
